CYCS and small cell lung carcinoma: A similar way of action was observed when two small cell lung carcinoma (SCLC) cell lines, GLC4 and its derived doxorubicin-resistant GLC4/ADR cell line, were treated with PG, apoptosis was induced by cytochrome C release, caspase cascade activation, and PARP cleavage, in a dose–response manner.